Open Prairie Ventures II, LP Invests in CPAC
September 23, 2008 - Open Prairie Ventures II, LP is pleased to announce its Series A investment in Compact Particle Acceleration Corp. (CPAC), a new venture in conjunction with TomoTherapy (NSADAQ: TOMO), targeted at developing the next generation in cancer treatment. CPAC is the third investment for Open Prairie Ventures II. The amount of the investment was not disclosed.
Open Prairie’s General Partner and CFO Dennis Beard said, “We believe CPAC is developing cutting-edge technology that will revolutionize the way we treat cancer and allow more patients the opportunity to live cancer free.”
“Open Prairie was a valuable contributor to TomoTherapy's success, beyond just the financing they provided. We are delighted that CPAC will benefit from Open Prairie's business guidance and impressive network," said Shawn Guse, CPAC CEO.